Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858)

China flag China · Delayed Price · Currency is CNY
16.88
+0.11 (0.66%)
Nov 19, 2024, 3:00 PM CST
-4.09%
Market Cap 18.12B
Revenue (ttm) 11.78B
Net Income (ttm) -293.31M
Shares Out 1.07B
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend 0.13 (0.74%)
Ex-Dividend Date Aug 20, 2024
Volume 4,589,276
Open 16.71
Previous Close 16.77
Day's Range 16.71 - 16.99
52-Week Range 14.15 - 19.70
Beta 0.52
Analysts n/a
Price Target n/a
Earnings Date Oct 28, 2024

About Shandong Buchang Pharmaceuticals

Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. The company offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. Shandong Buchang Pharmaceuticals Co., Ltd. was founded in 1993 and is based in Heze, China. [Read more]

Sector Healthcare
Founded 1993
Employees 8,311
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603858
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.